Are Glucose and Insulin Metabolism and Diabetes Associated with Migraine? A Community-Based, Case-Control Study

Aims: To investigate the association between glucose and insulin metabolism and migraine, as well as between diabetes mellitus (DM) and migraine, at a Chinese community level. Methods: A community-based, case-control study was performed in Heihe City, China. A survey was conducted door to door by eight trained investigators. Migraine was diagnosed using the International Classification of Headache Disorders (ICHD-III) beta criteria. A total of 2,023 participants completed a questionnaire, underwent a physical examination, and donated fasting blood. After excluding 191 with reported DM, 1,832 participants were included in the study. Of these, 86 participants with migraine and 95 without migraine participated in a 75-g oral glucose tolerance test. Glycosylated hemoglobin (HbA1c) was assessed at 0 minutes and serum glucose and insulin levels were measured at 0, 30, 60, and 120 minutes after glucose loading. Data with skewed distributions were compared using rank sum test, and the associations between DM and migraine were analyzed with logistic regression. Results: There were no significant differences in HbA1c, homeostatic model assessment-insulin resistance (HOMA-IR), β-cell function index of HOMA, or quantitative insulin sensitivity check index (QUICKI) between the participants with migraine and without migraine. When participants without migraine were classified into DM, prediabetes, and normal glucose subgroups and compared with the corresponding migraine subgroups, participants in the migraine subgroup with prediabetes presented higher levels of fasting insulin and HOMA-IR and a lower QUICKI than the nonmigraine subgroup with prediabetes. Moreover, DM was negatively associated with migraine in the 181 subjects who participated in the OGTT; however, no association was found when all 1,832 participants were considered. Conclusion: Insulin resistance seems to exist in individuals with both migraine and prediabetes, and there is a possible negative association between DM and migraine.

association; diabetes mellitus; insulin resistance; migraine

1. Rasmussen BK. Epidemiology of headache. Cephalalgia 2001; 21:774–777.

2. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163–2196.

3. Cavestro C, Rosatello A, Micca G, et al. Insulin metabolism is altered in migraineurs: A new pathogenic mechanism for migraine? Headache 2007;47:1436–1442.

4. Adashi EY, Hsueh AJ, Bambino TH, Yen SS. Disparate effect of clomiphene and tamoxifen on pituitary gonadotropin release in vitro. Am J Physiol 1981;240:e125–e130.

5. Sachs M, Pape HC, Speckmann EJ, Gorji A. The effect of estrogen and progesterone on spreading depression in rat neocortical tissues. Neurobiol Dis 2007;25:27–34.

6. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classicmigraine. Ann Neurol 1981;9:344–352.

7. Kim C, Siscovick DS, Sidney S, et al. Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: The CARDIA study. Coronary Artery Risk Development in Young Adults. Diabetes Care 2002;25:1027–1032.

8. Ryan RE. A controlled study of the effect of oral contraceptives on migraine. Headache 1978;17:250–252.

9. Rose FC. Trigger factors and natural history of migraine. Funct Neurol 1986;1:379–384.

10. Marsters JB, Mortimer MJ, Hay KM. Glucose and diet in the fasting migraineur. Headache 1986;26:243–247.

11. McCarthy LC, Hosford DA, Riley JH, et al. Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics 2001;78:135–149.

12. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001;24:539–548.

13. Rainero I, Limone P, Ferrero M, et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia 2005;25:593–597.

14. Fava A, Pirritano D, Consoli D, et al. Chronic migraine in women is associated with insulin resistance: A cross-sectional study. Eur J Neurol 2014;21:267–272.

15. Sacco S, Altobelli E, Ornello R, Ripa P, Pistoia F, Carolei A. Insulin resistance in migraineurs: Results from a case-control study. Cephalalgia 2014;34:349–356.

16. Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:948–959.

17. Burch RC, Rist PM, Winter AC, et al. Migraine and risk of incident diabetes in women: A prospective study. Cephalalgia 2012;32:991–997.

18. Berge LI, Riise T, Fasmer OB, et al. Does diabetes have a protective effect on migraine? Epidemiology 2013;24:129–134.

19. Aamodt AH, Stovner LJ, Midthjell K, Hagen K, Zwart JA. Headache prevalence related to diabetes mellitus. The HeadHUNT study. Eur J Neurol 2007;14:738–744.

20. Bushnell CD, Jamison M, James AH. Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ 2009;338:b664.

21. Hinnell C, Williams J, Metcalfe A, et al. Health status and health-related behaviors in epilepsy compared to other chronic conditions—A national population-based study. Epilepsia 2010; 51:853–861.

22. Wang X, San YZ, Sun JM, et al. Validation of the Chinese version of ID-migraine in medical students and systematic review with meta-analysis concerning its diagnostic accuracy. J Oral Facial Pain Headache 2015;29:265–278.

23. HKTDC Research. Heihe (Heilongjiang) City Information. http://china-trade-research.hktdc.com/business-news/article/Facts-and-Figures/Heihe-Heilongjiang-City-Information/ff/en/1/1X000000/1X09W9BY.htm. Accessed 21 June 2017.

24. Hong X. Thoughts on the sixth census of Heihe City. Heihe J 2013;(8):191.

25. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013; 33:629–808.

26. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(suppl):s62–s69.

27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.

28. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487–1495.

29. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402–2410.

30. Guldiken B, Guldiken S, Demir M, et al. Insulin resistance and high sensitivity C-reactive protein in migraine. Can J Neurol Sci 2008;35:448–451.

31. Yilmaz N, Aydin O, Yegin A, Titak A, Eren E, Aykal G. Impaired oxidative balance and association of blood glucose, insulin and HOMA-IR index in migraine. Biochem Med (Zagreb) 2011; 21:145–151.

32. Blau JN, Pyke DA. Effect of diabetes on migraine. Lancet 1970; 2:241–243.

33. Bao C, Zhang D, Sun B, et al. Optimal cut-off points of fasting plasma glucose for two-step strategy in estimating prevalence and screening undiagnosed diabetes and pre-diabetes in Harbin, China. PloS One 2015;10:e0119510.